Clearance of imipenem/cilastatin in acute renal failure patients treated by continuous hemodiafiltration (CAVHD)

This publication has 15 references indexed in Scilit:

• Determinants of Blood Flow and Ultrafiltration in Continuous Arteriovenous Haemodiafiltration: Theoretical Predictions and Laboratory and Clinical Observations
  Nephrology Dialysis Transplantation, 1990
• DOSAGE ADJUSTMENT OF DRUGS DURING CONTINUOUS HEMOFILTRATION
  1989
• Single-Dose Kinetics of Imipenem/Cilastatin During Continuous Arteriovenous Haemofiltration in Intensive Care Patients
  Nephrology Dialysis Transplantation, 1989
• Effect on growth curves and killing curves of brief exposure of Escherichia coli to imipenem and piperacillin
  Journal of Antimicrobial Chemotherapy, 1986
• The in-vivo postantibiotic effect of imipenem and other new antimicrobials
  Journal of Antimicrobial Chemotherapy, 1986
• Pharmacokinetics of Imipenem and Cilastatin in Volunteers
  Clinical Infectious Diseases, 1985
• Imipenem/cilastatin: Pharmacokinetic profile in renal insufficiency
  The American Journal of Medicine, 1985
• Carbapenems, a new class of beta-lactam antibiotics
  The American Journal of Medicine, 1985
• Determination of imipenem and cilastatin in serum by high-pressure liquid chromatography
  Antimicrobial Agents and Chemotherapy, 1984
• Determination of imipenem (N-formimidoyl thienamycin) in human plasma and urine by high-performance liquid chromatography, comparison with microbiological methodology and stability
  Journal of Chromatography B: Biomedical Sciences and Applications, 1984